Global Insomnia Medication Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Insomnia Medication Market Size was estimated at USD 3042.26 million in 2023 and is projected to reach USD 3718.09 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Insomnia Medication market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Medication Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Medication market in any manner.
Global Insomnia Medication Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Market Segmentation (by Type)
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Market Segmentation (by Application)
Adults
Kids
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Insomnia Medication Market Size was estimated at USD 3042.26 million in 2023 and is projected to reach USD 3718.09 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Insomnia Medication market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Medication Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Medication market in any manner.
Global Insomnia Medication Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Market Segmentation (by Type)
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Market Segmentation (by Application)
Adults
Kids
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Insomnia Medication Market
- Overview of the regional outlook of the Insomnia Medication Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Insomnia Medication
1.2 Key Market Segments
1.2.1 Insomnia Medication Segment by Type
1.2.2 Insomnia Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Medication Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Medication Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Medication Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Medication Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Medication Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Medication Sales Sites, Area Served, Product Type
3.6 Insomnia Medication Market Competitive Situation and Trends
3.6.1 Insomnia Medication Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Medication Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Medication Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Medication Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Medication Price by Type (2019-2024)
7 INSOMNIA MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Medication Market Sales by Application (2019-2024)
7.3 Global Insomnia Medication Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
8 INSOMNIA MEDICATION MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Medication Sales by Region
8.1.1 Global Insomnia Medication Sales by Region
8.1.2 Global Insomnia Medication Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Medication Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Medication Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Medication Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Medication Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Medication Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eisai
9.1.1 Eisai Insomnia Medication Basic Information
9.1.2 Eisai Insomnia Medication Product Overview
9.1.3 Eisai Insomnia Medication Product Market Performance
9.1.4 Eisai Business Overview
9.1.5 Eisai Insomnia Medication SWOT Analysis
9.1.6 Eisai Recent Developments
9.2 Merck
9.2.1 Merck Insomnia Medication Basic Information
9.2.2 Merck Insomnia Medication Product Overview
9.2.3 Merck Insomnia Medication Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Insomnia Medication SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Insomnia Medication Basic Information
9.3.2 Pfizer Insomnia Medication Product Overview
9.3.3 Pfizer Insomnia Medication Product Market Performance
9.3.4 Pfizer Insomnia Medication SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi Insomnia Medication Basic Information
9.4.2 Sanofi Insomnia Medication Product Overview
9.4.3 Sanofi Insomnia Medication Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Takeda
9.5.1 Takeda Insomnia Medication Basic Information
9.5.2 Takeda Insomnia Medication Product Overview
9.5.3 Takeda Insomnia Medication Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 Vanda Pharmaceuticals
9.6.1 Vanda Pharmaceuticals Insomnia Medication Basic Information
9.6.2 Vanda Pharmaceuticals Insomnia Medication Product Overview
9.6.3 Vanda Pharmaceuticals Insomnia Medication Product Market Performance
9.6.4 Vanda Pharmaceuticals Business Overview
9.6.5 Vanda Pharmaceuticals Recent Developments
9.7 Astellas
9.7.1 Astellas Insomnia Medication Basic Information
9.7.2 Astellas Insomnia Medication Product Overview
9.7.3 Astellas Insomnia Medication Product Market Performance
9.7.4 Astellas Business Overview
9.7.5 Astellas Recent Developments
9.8 Dainippon Sumitomo
9.8.1 Dainippon Sumitomo Insomnia Medication Basic Information
9.8.2 Dainippon Sumitomo Insomnia Medication Product Overview
9.8.3 Dainippon Sumitomo Insomnia Medication Product Market Performance
9.8.4 Dainippon Sumitomo Business Overview
9.8.5 Dainippon Sumitomo Recent Developments
9.9 ECR Pharmaceuticals (Valeant)
9.9.1 ECR Pharmaceuticals (Valeant) Insomnia Medication Basic Information
9.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Overview
9.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Market Performance
9.9.4 ECR Pharmaceuticals (Valeant) Business Overview
9.9.5 ECR Pharmaceuticals (Valeant) Recent Developments
9.10 Flynn Pharma
9.10.1 Flynn Pharma Insomnia Medication Basic Information
9.10.2 Flynn Pharma Insomnia Medication Product Overview
9.10.3 Flynn Pharma Insomnia Medication Product Market Performance
9.10.4 Flynn Pharma Business Overview
9.10.5 Flynn Pharma Recent Developments
9.11 Johnson and Johnson
9.11.1 Johnson and Johnson Insomnia Medication Basic Information
9.11.2 Johnson and Johnson Insomnia Medication Product Overview
9.11.3 Johnson and Johnson Insomnia Medication Product Market Performance
9.11.4 Johnson and Johnson Business Overview
9.11.5 Johnson and Johnson Recent Developments
9.12 Meda
9.12.1 Meda Insomnia Medication Basic Information
9.12.2 Meda Insomnia Medication Product Overview
9.12.3 Meda Insomnia Medication Product Market Performance
9.12.4 Meda Business Overview
9.12.5 Meda Recent Developments
9.13 Somnus Therapeutics
9.13.1 Somnus Therapeutics Insomnia Medication Basic Information
9.13.2 Somnus Therapeutics Insomnia Medication Product Overview
9.13.3 Somnus Therapeutics Insomnia Medication Product Market Performance
9.13.4 Somnus Therapeutics Business Overview
9.13.5 Somnus Therapeutics Recent Developments
9.14 Purdue Pharma
9.14.1 Purdue Pharma Insomnia Medication Basic Information
9.14.2 Purdue Pharma Insomnia Medication Product Overview
9.14.3 Purdue Pharma Insomnia Medication Product Market Performance
9.14.4 Purdue Pharma Business Overview
9.14.5 Purdue Pharma Recent Developments
9.15 Neurim
9.15.1 Neurim Insomnia Medication Basic Information
9.15.2 Neurim Insomnia Medication Product Overview
9.15.3 Neurim Insomnia Medication Product Market Performance
9.15.4 Neurim Business Overview
9.15.5 Neurim Recent Developments
9.16 Minerva Neurosciences
9.16.1 Minerva Neurosciences Insomnia Medication Basic Information
9.16.2 Minerva Neurosciences Insomnia Medication Product Overview
9.16.3 Minerva Neurosciences Insomnia Medication Product Market Performance
9.16.4 Minerva Neurosciences Business Overview
9.16.5 Minerva Neurosciences Recent Developments
9.17 Pernix Therapeutics
9.17.1 Pernix Therapeutics Insomnia Medication Basic Information
9.17.2 Pernix Therapeutics Insomnia Medication Product Overview
9.17.3 Pernix Therapeutics Insomnia Medication Product Market Performance
9.17.4 Pernix Therapeutics Business Overview
9.17.5 Pernix Therapeutics Recent Developments
9.18 SkyePharma
9.18.1 SkyePharma Insomnia Medication Basic Information
9.18.2 SkyePharma Insomnia Medication Product Overview
9.18.3 SkyePharma Insomnia Medication Product Market Performance
9.18.4 SkyePharma Business Overview
9.18.5 SkyePharma Recent Developments
9.19 Paratek Pharmaceuticals
9.19.1 Paratek Pharmaceuticals Insomnia Medication Basic Information
9.19.2 Paratek Pharmaceuticals Insomnia Medication Product Overview
9.19.3 Paratek Pharmaceuticals Insomnia Medication Product Market Performance
9.19.4 Paratek Pharmaceuticals Business Overview
9.19.5 Paratek Pharmaceuticals Recent Developments
10 INSOMNIA MEDICATION MARKET FORECAST BY REGION
10.1 Global Insomnia Medication Market Size Forecast
10.2 Global Insomnia Medication Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Medication Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Medication Market Size Forecast by Region
10.2.4 South America Insomnia Medication Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Medication by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Medication Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Medication by Type (2025-2030)
11.1.2 Global Insomnia Medication Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Medication by Type (2025-2030)
11.2 Global Insomnia Medication Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Medication Sales (Kilotons) Forecast by Application
11.2.2 Global Insomnia Medication Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Insomnia Medication
1.2 Key Market Segments
1.2.1 Insomnia Medication Segment by Type
1.2.2 Insomnia Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Medication Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Medication Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Medication Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Medication Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Medication Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Medication Sales Sites, Area Served, Product Type
3.6 Insomnia Medication Market Competitive Situation and Trends
3.6.1 Insomnia Medication Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Medication Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Medication Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Medication Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Medication Price by Type (2019-2024)
7 INSOMNIA MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Medication Market Sales by Application (2019-2024)
7.3 Global Insomnia Medication Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
8 INSOMNIA MEDICATION MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Medication Sales by Region
8.1.1 Global Insomnia Medication Sales by Region
8.1.2 Global Insomnia Medication Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Medication Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Medication Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Medication Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Medication Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Medication Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eisai
9.1.1 Eisai Insomnia Medication Basic Information
9.1.2 Eisai Insomnia Medication Product Overview
9.1.3 Eisai Insomnia Medication Product Market Performance
9.1.4 Eisai Business Overview
9.1.5 Eisai Insomnia Medication SWOT Analysis
9.1.6 Eisai Recent Developments
9.2 Merck
9.2.1 Merck Insomnia Medication Basic Information
9.2.2 Merck Insomnia Medication Product Overview
9.2.3 Merck Insomnia Medication Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Insomnia Medication SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Insomnia Medication Basic Information
9.3.2 Pfizer Insomnia Medication Product Overview
9.3.3 Pfizer Insomnia Medication Product Market Performance
9.3.4 Pfizer Insomnia Medication SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi Insomnia Medication Basic Information
9.4.2 Sanofi Insomnia Medication Product Overview
9.4.3 Sanofi Insomnia Medication Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Takeda
9.5.1 Takeda Insomnia Medication Basic Information
9.5.2 Takeda Insomnia Medication Product Overview
9.5.3 Takeda Insomnia Medication Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 Vanda Pharmaceuticals
9.6.1 Vanda Pharmaceuticals Insomnia Medication Basic Information
9.6.2 Vanda Pharmaceuticals Insomnia Medication Product Overview
9.6.3 Vanda Pharmaceuticals Insomnia Medication Product Market Performance
9.6.4 Vanda Pharmaceuticals Business Overview
9.6.5 Vanda Pharmaceuticals Recent Developments
9.7 Astellas
9.7.1 Astellas Insomnia Medication Basic Information
9.7.2 Astellas Insomnia Medication Product Overview
9.7.3 Astellas Insomnia Medication Product Market Performance
9.7.4 Astellas Business Overview
9.7.5 Astellas Recent Developments
9.8 Dainippon Sumitomo
9.8.1 Dainippon Sumitomo Insomnia Medication Basic Information
9.8.2 Dainippon Sumitomo Insomnia Medication Product Overview
9.8.3 Dainippon Sumitomo Insomnia Medication Product Market Performance
9.8.4 Dainippon Sumitomo Business Overview
9.8.5 Dainippon Sumitomo Recent Developments
9.9 ECR Pharmaceuticals (Valeant)
9.9.1 ECR Pharmaceuticals (Valeant) Insomnia Medication Basic Information
9.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Overview
9.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Market Performance
9.9.4 ECR Pharmaceuticals (Valeant) Business Overview
9.9.5 ECR Pharmaceuticals (Valeant) Recent Developments
9.10 Flynn Pharma
9.10.1 Flynn Pharma Insomnia Medication Basic Information
9.10.2 Flynn Pharma Insomnia Medication Product Overview
9.10.3 Flynn Pharma Insomnia Medication Product Market Performance
9.10.4 Flynn Pharma Business Overview
9.10.5 Flynn Pharma Recent Developments
9.11 Johnson and Johnson
9.11.1 Johnson and Johnson Insomnia Medication Basic Information
9.11.2 Johnson and Johnson Insomnia Medication Product Overview
9.11.3 Johnson and Johnson Insomnia Medication Product Market Performance
9.11.4 Johnson and Johnson Business Overview
9.11.5 Johnson and Johnson Recent Developments
9.12 Meda
9.12.1 Meda Insomnia Medication Basic Information
9.12.2 Meda Insomnia Medication Product Overview
9.12.3 Meda Insomnia Medication Product Market Performance
9.12.4 Meda Business Overview
9.12.5 Meda Recent Developments
9.13 Somnus Therapeutics
9.13.1 Somnus Therapeutics Insomnia Medication Basic Information
9.13.2 Somnus Therapeutics Insomnia Medication Product Overview
9.13.3 Somnus Therapeutics Insomnia Medication Product Market Performance
9.13.4 Somnus Therapeutics Business Overview
9.13.5 Somnus Therapeutics Recent Developments
9.14 Purdue Pharma
9.14.1 Purdue Pharma Insomnia Medication Basic Information
9.14.2 Purdue Pharma Insomnia Medication Product Overview
9.14.3 Purdue Pharma Insomnia Medication Product Market Performance
9.14.4 Purdue Pharma Business Overview
9.14.5 Purdue Pharma Recent Developments
9.15 Neurim
9.15.1 Neurim Insomnia Medication Basic Information
9.15.2 Neurim Insomnia Medication Product Overview
9.15.3 Neurim Insomnia Medication Product Market Performance
9.15.4 Neurim Business Overview
9.15.5 Neurim Recent Developments
9.16 Minerva Neurosciences
9.16.1 Minerva Neurosciences Insomnia Medication Basic Information
9.16.2 Minerva Neurosciences Insomnia Medication Product Overview
9.16.3 Minerva Neurosciences Insomnia Medication Product Market Performance
9.16.4 Minerva Neurosciences Business Overview
9.16.5 Minerva Neurosciences Recent Developments
9.17 Pernix Therapeutics
9.17.1 Pernix Therapeutics Insomnia Medication Basic Information
9.17.2 Pernix Therapeutics Insomnia Medication Product Overview
9.17.3 Pernix Therapeutics Insomnia Medication Product Market Performance
9.17.4 Pernix Therapeutics Business Overview
9.17.5 Pernix Therapeutics Recent Developments
9.18 SkyePharma
9.18.1 SkyePharma Insomnia Medication Basic Information
9.18.2 SkyePharma Insomnia Medication Product Overview
9.18.3 SkyePharma Insomnia Medication Product Market Performance
9.18.4 SkyePharma Business Overview
9.18.5 SkyePharma Recent Developments
9.19 Paratek Pharmaceuticals
9.19.1 Paratek Pharmaceuticals Insomnia Medication Basic Information
9.19.2 Paratek Pharmaceuticals Insomnia Medication Product Overview
9.19.3 Paratek Pharmaceuticals Insomnia Medication Product Market Performance
9.19.4 Paratek Pharmaceuticals Business Overview
9.19.5 Paratek Pharmaceuticals Recent Developments
10 INSOMNIA MEDICATION MARKET FORECAST BY REGION
10.1 Global Insomnia Medication Market Size Forecast
10.2 Global Insomnia Medication Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Medication Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Medication Market Size Forecast by Region
10.2.4 South America Insomnia Medication Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Medication by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Medication Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Medication by Type (2025-2030)
11.1.2 Global Insomnia Medication Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Medication by Type (2025-2030)
11.2 Global Insomnia Medication Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Medication Sales (Kilotons) Forecast by Application
11.2.2 Global Insomnia Medication Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Medication Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Medication Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Insomnia Medication Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Medication Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Medication Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
Table 10. Global Market Insomnia Medication Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Medication Sales Sites and Area Served
Table 12. Manufacturers Insomnia Medication Product Type
Table 13. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Medication
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Medication Market Challenges
Table 22. Global Insomnia Medication Sales by Type (Kilotons)
Table 23. Global Insomnia Medication Market Size by Type (M USD)
Table 24. Global Insomnia Medication Sales (Kilotons) by Type (2019-2024)
Table 25. Global Insomnia Medication Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Medication Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Medication Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Medication Price (USD/Ton) by Type (2019-2024)
Table 29. Global Insomnia Medication Sales (Kilotons) by Application
Table 30. Global Insomnia Medication Market Size by Application
Table 31. Global Insomnia Medication Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Insomnia Medication Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Medication Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Medication Market Share by Application (2019-2024)
Table 35. Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Insomnia Medication Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 43. Eisai Insomnia Medication Basic Information
Table 44. Eisai Insomnia Medication Product Overview
Table 45. Eisai Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eisai Business Overview
Table 47. Eisai Insomnia Medication SWOT Analysis
Table 48. Eisai Recent Developments
Table 49. Merck Insomnia Medication Basic Information
Table 50. Merck Insomnia Medication Product Overview
Table 51. Merck Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Insomnia Medication SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Pfizer Insomnia Medication Basic Information
Table 56. Pfizer Insomnia Medication Product Overview
Table 57. Pfizer Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Insomnia Medication SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi Insomnia Medication Basic Information
Table 62. Sanofi Insomnia Medication Product Overview
Table 63. Sanofi Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Takeda Insomnia Medication Basic Information
Table 67. Takeda Insomnia Medication Product Overview
Table 68. Takeda Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. Vanda Pharmaceuticals Insomnia Medication Basic Information
Table 72. Vanda Pharmaceuticals Insomnia Medication Product Overview
Table 73. Vanda Pharmaceuticals Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Vanda Pharmaceuticals Business Overview
Table 75. Vanda Pharmaceuticals Recent Developments
Table 76. Astellas Insomnia Medication Basic Information
Table 77. Astellas Insomnia Medication Product Overview
Table 78. Astellas Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Astellas Business Overview
Table 80. Astellas Recent Developments
Table 81. Dainippon Sumitomo Insomnia Medication Basic Information
Table 82. Dainippon Sumitomo Insomnia Medication Product Overview
Table 83. Dainippon Sumitomo Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Dainippon Sumitomo Business Overview
Table 85. Dainippon Sumitomo Recent Developments
Table 86. ECR Pharmaceuticals (Valeant) Insomnia Medication Basic Information
Table 87. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Overview
Table 88. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ECR Pharmaceuticals (Valeant) Business Overview
Table 90. ECR Pharmaceuticals (Valeant) Recent Developments
Table 91. Flynn Pharma Insomnia Medication Basic Information
Table 92. Flynn Pharma Insomnia Medication Product Overview
Table 93. Flynn Pharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Flynn Pharma Business Overview
Table 95. Flynn Pharma Recent Developments
Table 96. Johnson and Johnson Insomnia Medication Basic Information
Table 97. Johnson and Johnson Insomnia Medication Product Overview
Table 98. Johnson and Johnson Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Recent Developments
Table 101. Meda Insomnia Medication Basic Information
Table 102. Meda Insomnia Medication Product Overview
Table 103. Meda Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Meda Business Overview
Table 105. Meda Recent Developments
Table 106. Somnus Therapeutics Insomnia Medication Basic Information
Table 107. Somnus Therapeutics Insomnia Medication Product Overview
Table 108. Somnus Therapeutics Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Somnus Therapeutics Business Overview
Table 110. Somnus Therapeutics Recent Developments
Table 111. Purdue Pharma Insomnia Medication Basic Information
Table 112. Purdue Pharma Insomnia Medication Product Overview
Table 113. Purdue Pharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Purdue Pharma Business Overview
Table 115. Purdue Pharma Recent Developments
Table 116. Neurim Insomnia Medication Basic Information
Table 117. Neurim Insomnia Medication Product Overview
Table 118. Neurim Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Neurim Business Overview
Table 120. Neurim Recent Developments
Table 121. Minerva Neurosciences Insomnia Medication Basic Information
Table 122. Minerva Neurosciences Insomnia Medication Product Overview
Table 123. Minerva Neurosciences Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Minerva Neurosciences Business Overview
Table 125. Minerva Neurosciences Recent Developments
Table 126. Pernix Therapeutics Insomnia Medication Basic Information
Table 127. Pernix Therapeutics Insomnia Medication Product Overview
Table 128. Pernix Therapeutics Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Pernix Therapeutics Business Overview
Table 130. Pernix Therapeutics Recent Developments
Table 131. SkyePharma Insomnia Medication Basic Information
Table 132. SkyePharma Insomnia Medication Product Overview
Table 133. SkyePharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. SkyePharma Business Overview
Table 135. SkyePharma Recent Developments
Table 136. Paratek Pharmaceuticals Insomnia Medication Basic Information
Table 137. Paratek Pharmaceuticals Insomnia Medication Product Overview
Table 138. Paratek Pharmaceuticals Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Paratek Pharmaceuticals Business Overview
Table 140. Paratek Pharmaceuticals Recent Developments
Table 141. Global Insomnia Medication Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Insomnia Medication Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Insomnia Medication Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Insomnia Medication Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Insomnia Medication Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Insomnia Medication Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Insomnia Medication Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Insomnia Medication Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Insomnia Medication Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Insomnia Medication Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Medication Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Medication Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Insomnia Medication Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Medication Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Medication Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
Table 10. Global Market Insomnia Medication Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Medication Sales Sites and Area Served
Table 12. Manufacturers Insomnia Medication Product Type
Table 13. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Medication
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Medication Market Challenges
Table 22. Global Insomnia Medication Sales by Type (Kilotons)
Table 23. Global Insomnia Medication Market Size by Type (M USD)
Table 24. Global Insomnia Medication Sales (Kilotons) by Type (2019-2024)
Table 25. Global Insomnia Medication Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Medication Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Medication Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Medication Price (USD/Ton) by Type (2019-2024)
Table 29. Global Insomnia Medication Sales (Kilotons) by Application
Table 30. Global Insomnia Medication Market Size by Application
Table 31. Global Insomnia Medication Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Insomnia Medication Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Medication Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Medication Market Share by Application (2019-2024)
Table 35. Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Insomnia Medication Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Insomnia Medication Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Insomnia Medication Sales by Region (2019-2024) & (Kilotons)
Table 43. Eisai Insomnia Medication Basic Information
Table 44. Eisai Insomnia Medication Product Overview
Table 45. Eisai Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eisai Business Overview
Table 47. Eisai Insomnia Medication SWOT Analysis
Table 48. Eisai Recent Developments
Table 49. Merck Insomnia Medication Basic Information
Table 50. Merck Insomnia Medication Product Overview
Table 51. Merck Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Insomnia Medication SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Pfizer Insomnia Medication Basic Information
Table 56. Pfizer Insomnia Medication Product Overview
Table 57. Pfizer Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Insomnia Medication SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi Insomnia Medication Basic Information
Table 62. Sanofi Insomnia Medication Product Overview
Table 63. Sanofi Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Takeda Insomnia Medication Basic Information
Table 67. Takeda Insomnia Medication Product Overview
Table 68. Takeda Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. Vanda Pharmaceuticals Insomnia Medication Basic Information
Table 72. Vanda Pharmaceuticals Insomnia Medication Product Overview
Table 73. Vanda Pharmaceuticals Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Vanda Pharmaceuticals Business Overview
Table 75. Vanda Pharmaceuticals Recent Developments
Table 76. Astellas Insomnia Medication Basic Information
Table 77. Astellas Insomnia Medication Product Overview
Table 78. Astellas Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Astellas Business Overview
Table 80. Astellas Recent Developments
Table 81. Dainippon Sumitomo Insomnia Medication Basic Information
Table 82. Dainippon Sumitomo Insomnia Medication Product Overview
Table 83. Dainippon Sumitomo Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Dainippon Sumitomo Business Overview
Table 85. Dainippon Sumitomo Recent Developments
Table 86. ECR Pharmaceuticals (Valeant) Insomnia Medication Basic Information
Table 87. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Overview
Table 88. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ECR Pharmaceuticals (Valeant) Business Overview
Table 90. ECR Pharmaceuticals (Valeant) Recent Developments
Table 91. Flynn Pharma Insomnia Medication Basic Information
Table 92. Flynn Pharma Insomnia Medication Product Overview
Table 93. Flynn Pharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Flynn Pharma Business Overview
Table 95. Flynn Pharma Recent Developments
Table 96. Johnson and Johnson Insomnia Medication Basic Information
Table 97. Johnson and Johnson Insomnia Medication Product Overview
Table 98. Johnson and Johnson Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Recent Developments
Table 101. Meda Insomnia Medication Basic Information
Table 102. Meda Insomnia Medication Product Overview
Table 103. Meda Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Meda Business Overview
Table 105. Meda Recent Developments
Table 106. Somnus Therapeutics Insomnia Medication Basic Information
Table 107. Somnus Therapeutics Insomnia Medication Product Overview
Table 108. Somnus Therapeutics Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Somnus Therapeutics Business Overview
Table 110. Somnus Therapeutics Recent Developments
Table 111. Purdue Pharma Insomnia Medication Basic Information
Table 112. Purdue Pharma Insomnia Medication Product Overview
Table 113. Purdue Pharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Purdue Pharma Business Overview
Table 115. Purdue Pharma Recent Developments
Table 116. Neurim Insomnia Medication Basic Information
Table 117. Neurim Insomnia Medication Product Overview
Table 118. Neurim Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Neurim Business Overview
Table 120. Neurim Recent Developments
Table 121. Minerva Neurosciences Insomnia Medication Basic Information
Table 122. Minerva Neurosciences Insomnia Medication Product Overview
Table 123. Minerva Neurosciences Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Minerva Neurosciences Business Overview
Table 125. Minerva Neurosciences Recent Developments
Table 126. Pernix Therapeutics Insomnia Medication Basic Information
Table 127. Pernix Therapeutics Insomnia Medication Product Overview
Table 128. Pernix Therapeutics Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Pernix Therapeutics Business Overview
Table 130. Pernix Therapeutics Recent Developments
Table 131. SkyePharma Insomnia Medication Basic Information
Table 132. SkyePharma Insomnia Medication Product Overview
Table 133. SkyePharma Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. SkyePharma Business Overview
Table 135. SkyePharma Recent Developments
Table 136. Paratek Pharmaceuticals Insomnia Medication Basic Information
Table 137. Paratek Pharmaceuticals Insomnia Medication Product Overview
Table 138. Paratek Pharmaceuticals Insomnia Medication Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Paratek Pharmaceuticals Business Overview
Table 140. Paratek Pharmaceuticals Recent Developments
Table 141. Global Insomnia Medication Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Insomnia Medication Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Insomnia Medication Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Insomnia Medication Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Insomnia Medication Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Insomnia Medication Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Insomnia Medication Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Insomnia Medication Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Insomnia Medication Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Insomnia Medication Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Insomnia Medication Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Insomnia Medication Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Insomnia Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Medication Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Medication Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Medication Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Medication Market Size by Country (M USD)
Figure 11. Insomnia Medication Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Medication Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Medication Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Medication Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Medication Market Share by Type
Figure 18. Sales Market Share of Insomnia Medication by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Medication by Type in 2023
Figure 20. Market Size Share of Insomnia Medication by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Medication by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Medication Market Share by Application
Figure 24. Global Insomnia Medication Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Medication Sales Market Share by Application in 2023
Figure 26. Global Insomnia Medication Market Share by Application (2019-2024)
Figure 27. Global Insomnia Medication Market Share by Application in 2023
Figure 28. Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Medication Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Insomnia Medication Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Insomnia Medication Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Medication Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Insomnia Medication Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Insomnia Medication Sales Market Share by Region in 2023
Figure 44. China Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 50. South America Insomnia Medication Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Insomnia Medication Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Insomnia Medication Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Insomnia Medication Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Medication Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Medication Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Medication Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Medication Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Insomnia Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Medication Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Medication Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Medication Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Medication Market Size by Country (M USD)
Figure 11. Insomnia Medication Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Medication Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Medication Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Medication Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Medication Market Share by Type
Figure 18. Sales Market Share of Insomnia Medication by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Medication by Type in 2023
Figure 20. Market Size Share of Insomnia Medication by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Medication by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Medication Market Share by Application
Figure 24. Global Insomnia Medication Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Medication Sales Market Share by Application in 2023
Figure 26. Global Insomnia Medication Market Share by Application (2019-2024)
Figure 27. Global Insomnia Medication Market Share by Application in 2023
Figure 28. Global Insomnia Medication Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Medication Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Insomnia Medication Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Insomnia Medication Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Medication Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Insomnia Medication Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Insomnia Medication Sales Market Share by Region in 2023
Figure 44. China Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 50. South America Insomnia Medication Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Insomnia Medication Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Insomnia Medication Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Insomnia Medication Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Insomnia Medication Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Insomnia Medication Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Medication Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Medication Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Medication Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Medication Market Share Forecast by Application (2025-2030)
